Reports
Reports
The synthetic biology market is growing considerably as a result of adoption of advanced technologies in genetic engineering, bioinformatics, and bio manufacturing. New technologies such as CRISPR-Cas9, gene synthesis platforms, and cell-free systems have enabled biologists to design and program biological systems with unprecedented specificity.
This growth is coming from a variety of players in the industry-a deep-tech startup or huge biopharma company, or a specialized tool provider. Some examples include an automated DNA synthesis machine that offers GM constructs quicker, cheaper, and more reliably, with expedited development times for the biotechnology firms looking to use synthetic biology to yield more therapeutics, diagnostics, or sustainable chemicals.
.webp "Synthetic Biology Market Revenue Growth (USD Bn)")
The introduction of significant new resources collected from, for example, collaborative efforts between academia and commercial entities are assisting significant and sometimes needed advances into the initiatives and ecosystem of synthetic biology.
Coupling increased investment from venture capital and governmental funding (and granting funding) in synthetic biology initiatives, particularly the biosafety or environmentally-sensitive biosensing, it makes sense that the entire space is scaling strongly. For all the synthetic biology players all over the value chain-from gene editing services to bio-design software-all of them will expand, invest, and/or partner, and therefore eclectically boost momentum in the space.
The growth of the synthetic biology industry has been remarkable in recent years with metrics clearly demonstrating that it is on an upward trajectory. Venture capital financing has more than doubled over the past five years, and it is seen now as funding moves into many new applications such as precision fermentation, bio-based materials, cell therapeutics, and agricultural biotech.
The number of synthetic biology companies has increased globally more than any other biotech subsector. New company formations are increasing faster than any other subsector. Patent applications across synthetic gene circuits, chassis microorganisms, and metabolic engineering are increasing by 15-20% each year, which is a clear indicator of the level of innovation activity in this space.
Additionally, the number of GMP facilities that can produce biologics derived from synthetic biology has increased by more than 30% in the last three years - indicating that the underlying manufacturing infrastructure is maturing. Collaborations with synthetic biology experts and the major industries including consumer goods, agrochemicals and pharma of scale have increased threefold, indicating broadening interest.
Finally, publications in leading journals on scalable bio-production and synthetic genome assembly have also increased by approximately 25% annually, which shows strong academic/studies momentum. Collectively, this all demonstrates a market that is growing not just in financial terms but also in innovation, infrastructure, and industry integration.
| Attribute | Detail |
|---|---|
| Synthetic Biology Market Drivers |
|
One of the biggest factors behind the synthetic biology market's growth is the drastic reduction in the costs associated with biomanufacturing. Companies are producing chemicals, enzymes, and therapeutic proteins (biologics) at cheaper prices. Through breakthroughs in strain engineering and fermentation optimization; companies are investing in better strains, optimizing synthetic pathways, and improved bioreactor designs.
Centralized collaborators or strategic partnerships with firms will receive investment by both - early stage start and matured companies looking to be able to scale up products and improve yields that will ultimately reduce process costs. Biomanufacturers are interested in cell line engineering, which allows for development timelines to be decreased for scale and increases yield in the biomanufacturing process, creating a pathway to lower costs in biomanufacturing.
DNA synthesis prices have come down significantly. DNA that once cost tens of dollars per gene is now a few cents per base pair. Companies that offer drop-in replacements for petrochemical-derived compounds (cosmetics, food ingredients, and industrial monomers) claim to be able to match petroleum-derived products and sometimes beat petroleum pricing through synthetic biology.
These economic factors are motivating pharmaceutical incumbents to partner with synthetic biology firms, and additional companies are stepping into the market. The market has developed a trajectory towards acceleration; costs are being reduced, product development and process costs are driving manufacturing forward through extended applications, and labs are moving to reallocate resources towards experimentation and innovation at the same time as costs are being brought down.
The major driver of growth is the availability of customizable design tools (software platforms, automated lab systems and modular genetic parts) that facilitate biological engineering. Design-build-test-learn (DBTL) platforms support streamlined workflows and less trial-and-error with broad access to synthetic biology. For example, cloud-based design tools that allows one to design genetic circuits or metabolic pathways, simulate their putative performance, and connected directly to DNA synthesis services eliminates traditional bottlenecks in workflows. Researchers first design in silico, decide to use DAC, and then print DNA to physically prototype their designs.
Lab automation platforms that have robotics for liquid handling and automated high-throughput screening enable faster cycles of experimentation. For example, teams can run dozens of enzyme variants in parallel, with each enzyme tested under different conditions, to rapidly narrow down selection of good candidates.
With standardized modular toolkit components (standardized promoters, ribosome-binding sites, scaffolds, and chassis organisms), users can mix and match these parts to develop bespoke applications without needing deep biological engineering expertise. This has already enabled businesses to clear a `proof-of-concept` product from bio-based pigments to environmental sensors in a short period, reducing both - time-to-market and risk. While reducing technical barriers and providing flexible, precise control over biological constructs, this approach also indirectly encourages wider adoption and growth markets.
Oligonucleotides and synthetic DNA comprise the largest part of the global synthetic biology marketplace as they serve as a basis for genetic engineering obtaining genetic material necessary for use in life sciences fields such as diagnostics and therapeutics. Oligonucleotides, which are short sequences of DNA or RNA, are needed for gene synthesis, CRISPR-based genome editing, or design of synthetic gene circuits.
Oligonucleotide synthesis offers high precision, replicability across size scales, and lowering synthesis costs, which enables growing acceptance across many sectors including biotechnology, pharmaceutical, and agriculture. With increasing use of personalized medicines, mRNA-based vaccines, cell and gene therapies, the demand for well characterized, affordable and flexible manufacturing capacity presents a fast growing opportunity for investment into the technologies that facilitate oligonucleotide production.
The use of oligonucleotides for rapid prototyping biological systems as a growth area, for example, engineered microbes for bio-manufacturing or engineered crops for sustainable agriculture, is becoming clearer every day. Capability in oligonucleotide production continues to improve with the advancement of DNA synthesis manufacturer platforms, the introduction automated synthesis units, and development of high fidelity error correction tools in most synthesis platforms.
Increased government investment, large private sector funding, and the rise in startup interest within the space of synthetic biology are also providing a boost to this area in the microcosm of synthetic biology.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
North America is at the forefront of innovation and commercialization of synthetic biology supported by strong institutional support, investment from venture capital, and sound infrastructure. The U.S. participates with over 60% of the total synthetic biology venture capital financing and has approximately 70% of the global synthetic biology start-ups.
Many of the U.S.-headquartered companies are emerging as leaders in computational biology platforms and cell programming tools, including many in biotech city regions of Boston, San Francisco, and San Diego. Federal efforts increasing public agency funding to the bioeconomy have been another way to further strengthen its position to lead.
The U.S. also has a broad network of contract development and manufacturing organizations (CDMOs) that can push synthetic constructs into clinical and commercial volumes. For example, one midwestern U.S.-based CDMO recently tripled the number of patient iterations in a manufacturing run by producing synthetic RNA therapeutics at GMP scale, which would be impossible for a small startup.
Partnership activity is also strong, with large American consumer goods and agrochemical firms regularly collaborating with synthetic biology companies to incorporate bio-based ingredients in their products. Moreover, there are several state-level programs (for example: California and Massachusetts) that provide grants and infrastructure to synthetic biology start-ups to support their development and entrench their regional dominance in synthetic biology.
Key players operating in the synthetic biology industry are investing through innovation, technological advancements, and strategic partnerships. They focus on enhancing imaging clarity, and expanding product portfolios, ensuring sustained growth and leadership in the evolving healthcare landscape.
Ginkgo Bioworks, Bolt Threads, Mammoth Biosciences, LanzaTech, Motif FoodWorks, Joyn Bio, Kiverdi, Perfect Day, Viridos, Upside Foods, Asimov, Apeel, & Twist Bioscience are the key players in synthetic biology market.
Each of these players has been profiled in the synthetic biology market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Size in 2024 | US$ 18.9 Bn |
| Forecast Value in 2035 | US$ 84.7 Bn |
| CAGR | 14.1% |
| Forecast Period | 2025-2035 |
| Historical Data Available for | 2020-2023 |
| Quantitative Units | US$ Bn |
| Synthetic Biology Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
The synthetic biology market was valued at US$ 18.9 Bn in 2024.
The synthetic biology market is projected to cross US$ 84.7 Bn by the end of 2035.
Reduction in the cost of bio manufacturing and growth in customizable Bio-Design Tools.
The CAGR is anticipated to be 14.1% from 2025 to 2035.
North America is expected to account for the largest share from 2025 to 2035.
Ginkgo Bioworks, Bolt Threads, Mammoth Biosciences, LanzaTech, Motif FoodWorks, Joyn Bio, Kiverdi, Perfect Day, Viridos, Upside Foods, Asimov, Apeel, & Twist Bioscience, and others
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Synthetic Biology Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Synthetic Biology Market Analysis and Forecast, 2020 to 2035
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Regulatory Landscape across Key Regions/Countries
5.2. Recent Technological Advancements in Chimeric Antigen Receptor T-cell Therapy
5.3. Pricing Trends
5.4. PORTER’s Five Forces Analysis
5.5. PESTEL Analysis
5.6. Key Industry Events (Partnerships, Collaborations, Mergers & acquisitions, funding and investments, etc.)
5.7. Value Chain Analysis
5.8. Technology Analysis
5.9. Key Purchase Metrics for the end-users
5.10. Unmet needs of the market
6. Global Synthetic Biology Market Analysis and Forecast, by Tools
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Tools, 2020 to 2035
6.3.1. Oligonucleotides & Synthetic DNA
6.3.2. Enzymes
6.3.3. Cloning Technology Kits
6.3.4. Synthetic Cells
6.3.5. Chassis Organisms
6.3.6. Others
6.4. Market Attractiveness Analysis, by Tools
7. Global Synthetic Biology Market Analysis and Forecast, by Technology
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2020 to 2035
7.3.1. Gene Synthesis
7.3.2. Genome Engineering
7.3.3. Sequencing
7.3.4. Bioinformatics
7.3.5. Cloning
7.3.6. Site-Directed Mutagenesis
7.3.7. Others
7.4. Market Attractiveness Analysis, by Technology
8. Global Synthetic Biology Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2020 to 2035
8.3.1. Biosensors
8.3.2. Biological Computers
8.3.3. Cell Transformation
8.3.4. Proteins Designing
8.3.5. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Synthetic Biology Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020 to 2035
9.3.1. Healthcare
9.3.1.1. Cell-based Therapies & Diagnostics
9.3.1.2. New Antimicrobials
9.3.1.3. Pharmaceutical Manufacturing
9.3.1.4. Others
9.3.2. Industry
9.3.2.1. Biofuels
9.3.2.2. Biomaterials
9.3.2.3. Chemical Manufacturing
9.3.2.4. Others
9.3.3. Environment
9.3.3.1. Remediation
9.3.3.2. Biosensing
9.3.4. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Synthetic Biology Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020 to 2035
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Region
11. North America Synthetic Biology Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Tools, 2020 to 2035
11.2.1. Oligonucleotides & Synthetic DNA
11.2.2. Enzymes
11.2.3. Cloning Technology Kits
11.2.4. Synthetic Cells
11.2.5. Chassis Organisms
11.2.6. Others
11.3. Market Value Forecast, by Technology, 2020 to 2035
11.3.1. Gene Synthesis
11.3.2. Genome Engineering
11.3.3. Sequencing
11.3.4. Bioinformatics
11.3.5. Cloning
11.3.6. Site-Directed Mutagenesis
11.3.7. Others
11.4. Market Value Forecast, by Application, 2020 to 2035
11.4.1. Biosensors
11.4.2. Biological Computers
11.4.3. Cell Transformation
11.4.4. Proteins Designing
11.4.5. Others
11.5. Market Value Forecast, by End-user, 2020 to 2035
11.5.1. Healthcare
11.5.1.1. Cell-based Therapies & Diagnostics
11.5.1.2. New Antimicrobials
11.5.1.3. Pharmaceutical Manufacturing
11.5.1.4. Others
11.5.2. Industry
11.5.2.1. Biofuels
11.5.2.2. Biomaterials
11.5.2.3. Chemical Manufacturing
11.5.2.4. Others
11.5.3. Environment
11.5.3.1. Remediation
11.5.3.2. Biosensing
11.5.4. Others
11.6. Market Value Forecast, by Country, 2020 to 2035
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Tools
11.7.2. By Technology
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Synthetic Biology Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Tools, 2020 to 2035
12.2.1. Oligonucleotides & Synthetic DNA
12.2.2. Enzymes
12.2.3. Cloning Technology Kits
12.2.4. Synthetic Cells
12.2.5. Chassis Organisms
12.2.6. Others
12.3. Market Value Forecast, by Technology, 2020 to 2035
12.3.1. Gene Synthesis
12.3.2. Genome Engineering
12.3.3. Sequencing
12.3.4. Bioinformatics
12.3.5. Cloning
12.3.6. Site-Directed Mutagenesis
12.3.7. Others
12.4. Market Value Forecast, by Application, 2020 to 2035
12.4.1. Biosensors
12.4.2. Biological Computers
12.4.3. Cell Transformation
12.4.4. Proteins Designing
12.4.5. Others
12.5. Market Value Forecast, by End-user, 2020 to 2035
12.5.1. Healthcare
12.5.1.1. Cell-based Therapies & Diagnostics
12.5.1.2. New Antimicrobials
12.5.1.3. Pharmaceutical Manufacturing
12.5.1.4. Others
12.5.2. Industry
12.5.2.1. Biofuels
12.5.2.2. Biomaterials
12.5.2.3. Chemical Manufacturing
12.5.2.4. Others
12.5.3. Environment
12.5.3.1. Remediation
12.5.3.2. Biosensing
12.5.4. Others
12.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Switzerland
12.6.7. The Netherlands
12.6.8. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Tools
12.7.2. By Technology
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Synthetic Biology Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Tools, 2020 to 2035
13.2.1. Oligonucleotides & Synthetic DNA
13.2.2. Enzymes
13.2.3. Cloning Technology Kits
13.2.4. Synthetic Cells
13.2.5. Chassis Organisms
13.2.6. Others
13.3. Market Value Forecast, by Technology, 2020 to 2035
13.3.1. Gene Synthesis
13.3.2. Genome Engineering
13.3.3. Sequencing
13.3.4. Bioinformatics
13.3.5. Cloning
13.3.6. Site-Directed Mutagenesis
13.3.7. Others
13.4. Market Value Forecast, by Application, 2020 to 2035
13.4.1. Biosensors
13.4.2. Biological Computers
13.4.3. Cell Transformation
13.4.4. Proteins Designing
13.4.5. Others
13.5. Market Value Forecast, by End-user, 2020 to 2035
13.5.1. Healthcare
13.5.1.1. Cell-based Therapies & Diagnostics
13.5.1.2. New Antimicrobials
13.5.1.3. Pharmaceutical Manufacturing
13.5.1.4. Others
13.5.2. Industry
13.5.2.1. Biofuels
13.5.2.2. Biomaterials
13.5.2.3. Chemical Manufacturing
13.5.2.4. Others
13.5.3. Environment
13.5.3.1. Remediation
13.5.3.2. Biosensing
13.5.4. Others
13.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
13.6.1. China
13.6.2. India
13.6.3. Japan
13.6.4. South Korea
13.6.5. Australia & New Zealand
13.6.6. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Tools
13.7.2. By Technology
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Synthetic Biology Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Tools, 2020 to 2035
14.2.1. Oligonucleotides & Synthetic DNA
14.2.2. Enzymes
14.2.3. Cloning Technology Kits
14.2.4. Synthetic Cells
14.2.5. Chassis Organisms
14.2.6. Others
14.3. Market Value Forecast, by Technology, 2020 to 2035
14.3.1. Gene Synthesis
14.3.2. Genome Engineering
14.3.3. Sequencing
14.3.4. Bioinformatics
14.3.5. Cloning
14.3.6. Site-Directed Mutagenesis
14.3.7. Others
14.4. Market Value Forecast, by Application, 2020 to 2035
14.4.1. Biosensors
14.4.2. Biological Computers
14.4.3. Cell Transformation
14.4.4. Proteins Designing
14.4.5. Others
14.5. Market Value Forecast, by End-user, 2020 to 2035
14.5.1. Healthcare
14.5.1.1. Cell-based Therapies & Diagnostics
14.5.1.2. New Antimicrobials
14.5.1.3. Pharmaceutical Manufacturing
14.5.1.4. Others
14.5.2. Industry
14.5.2.1. Biofuels
14.5.2.2. Biomaterials
14.5.2.3. Chemical Manufacturing
14.5.2.4. Others
14.5.3. Environment
14.5.3.1. Remediation
14.5.3.2. Biosensing
14.5.4. Others
14.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Argentina
14.6.4. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Tools
14.7.2. By Technology
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Synthetic Biology Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Tools, 2020 to 2035
15.2.1. Oligonucleotides & Synthetic DNA
15.2.2. Enzymes
15.2.3. Cloning Technology Kits
15.2.4. Synthetic Cells
15.2.5. Chassis Organisms
15.2.6. Others
15.3. Market Value Forecast, by Technology, 2020 to 2035
15.3.1. Gene Synthesis
15.3.2. Genome Engineering
15.3.3. Sequencing
15.3.4. Bioinformatics
15.3.5. Cloning
15.3.6. Site-Directed Mutagenesis
15.3.7. Others
15.4. Market Value Forecast, by Application, 2020 to 2035
15.4.1. Biosensors
15.4.2. Biological Computers
15.4.3. Cell Transformation
15.4.4. Proteins Designing
15.4.5. Others
15.5. Market Value Forecast, by End-user, 2020 to 2035
15.5.1. Healthcare
15.5.1.1. Cell-based Therapies & Diagnostics
15.5.1.2. New Antimicrobials
15.5.1.3. Pharmaceutical Manufacturing
15.5.1.4. Others
15.5.2. Industry
15.5.2.1. Biofuels
15.5.2.2. Biomaterials
15.5.2.3. Chemical Manufacturing
15.5.2.4. Others
15.5.3. Environment
15.5.3.1. Remediation
15.5.3.2. Biosensing
15.5.4. Others
15.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Tools
15.7.2. By Technology
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of companies)
16.2. Market Share Analysis, by Company (2024)
16.3. Company Profiles
16.3.1. Ginkgo Bioworks
16.3.1.1. Company Overview
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. Business Strategies
16.3.1.5. Recent Developments
16.3.2. Bolt Threads
16.3.2.1. Company Overview
16.3.2.2. Financial Overview
16.3.2.3. Product Portfolio
16.3.2.4. Business Strategies
16.3.2.5. Recent Developments
16.3.3. Mammoth Biosciences
16.3.3.1. Company Overview
16.3.3.2. Financial Overview
16.3.3.3. Product Portfolio
16.3.3.4. Business Strategies
16.3.3.5. Recent Developments
16.3.4. LanzaTech
16.3.4.1. Company Overview
16.3.4.2. Financial Overview
16.3.4.3. Product Portfolio
16.3.4.4. Business Strategies
16.3.4.5. Recent Developments
16.3.5. Motif FoodWorks
16.3.5.1. Company Overview
16.3.5.2. Financial Overview
16.3.5.3. Product Portfolio
16.3.5.4. Business Strategies
16.3.5.5. Recent Developments
16.3.6. Joyn Bio
16.3.6.1. Company Overview
16.3.6.2. Financial Overview
16.3.6.3. Product Portfolio
16.3.6.4. Business Strategies
16.3.6.5. Recent Developments
16.3.7. Kiverdi
16.3.7.1. Company Overview
16.3.7.2. Financial Overview
16.3.7.3. Product Portfolio
16.3.7.4. Business Strategies
16.3.7.5. Recent Developments
16.3.8. Perfect Day
16.3.8.1. Company Overview
16.3.8.2. Financial Overview
16.3.8.3. Product Portfolio
16.3.8.4. Business Strategies
16.3.8.5. Recent Developments
16.3.9. Viridos
16.3.9.1. Company Overview
16.3.9.2. Financial Overview
16.3.9.3. Product Portfolio
16.3.9.4. Business Strategies
16.3.9.5. Recent Developments
16.3.10. Asimov
16.3.10.1. Company Overview
16.3.10.2. Financial Overview
16.3.10.3. Product Portfolio
16.3.10.4. Business Strategies
16.3.10.5. Recent Developments
16.3.11. Apeel
16.3.11.1. Company Overview
16.3.11.2. Financial Overview
16.3.11.3. Product Portfolio
16.3.11.4. Business Strategies
16.3.11.5. Recent Developments
16.3.12. Twist Bioscience
16.3.12.1. Company Overview
16.3.12.2. Financial Overview
16.3.12.3. Product Portfolio
16.3.12.4. Business Strategies
16.3.12.5. Recent Developments
16.3.13. Upside Foods
16.3.13.1. Company Overview
16.3.13.2. Financial Overview
16.3.13.3. Product Portfolio
16.3.13.4. Business Strategies
16.3.13.5. Recent Developments
List of Tables
Table 01: Global Synthetic Biology Market Value (US$ Bn) Forecast, by Tools, 2020 to 2035
Table 02: Global Synthetic Biology Market Value (US$ Bn) Forecast, By Technology, 2020 to 2035
Table 03: Global Synthetic Biology Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
Table 04: Global Synthetic Biology Market Value (US$ Bn) Forecast, by End-user, 2020 to 2035
Table 05: Global Synthetic Biology Market Value (US$ Bn) Forecast, by Healthcare, 2020 to 2035
Table 06: Global Synthetic Biology Market Value (US$ Bn) Forecast, by Industry, 2020 to 2035
Table 07: Global Synthetic Biology Market Value (US$ Bn) Forecast, by Environment, 2020 to 2035
Table 08: Global Synthetic Biology Market Value (US$ Bn) Forecast, By Region, 2020 to 2035
Table 09: North America Synthetic Biology Market Value (US$ Bn) Forecast, by Country, 2020-2035
Table 10: North America Synthetic Biology Market Value (US$ Bn) Forecast, by Tools, 2020 to 2035
Table 11: North America Synthetic Biology Market Value (US$ Bn) Forecast, by Technology, 2020 to 2035
Table 12: North America Synthetic Biology Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
Table 13: North America Synthetic Biology Market Value (US$ Bn) Forecast, by End-user, 2020 to 2035
Table 14: North America Synthetic Biology Market Value (US$ Bn) Forecast, by Healthcare, 2020 to 2035
Table 15: North America Synthetic Biology Market Value (US$ Bn) Forecast, by Industry, 2020 to 2035
Table 16: North America Synthetic Biology Market Value (US$ Bn) Forecast, by Environment, 2020 to 2035
Table 17: Europe Synthetic Biology Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2035
Table 18: Europe Synthetic Biology Market Value (US$ Bn) Forecast, by Tools, 2020 to 2035
Table 19: Europe Synthetic Biology Market Value (US$ Bn) Forecast, by Technology, 2020 to 2035
Table 20: Europe Synthetic Biology Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
Table 21: Europe Synthetic Biology Market Value (US$ Bn) Forecast, by End-user, 2020 to 2035
Table 22: Europe Synthetic Biology Market Value (US$ Bn) Forecast, by Healthcare, 2020 to 2035
Table 23: Europe Synthetic Biology Market Value (US$ Bn) Forecast, by Industry, 2020 to 2035
Table 24: Europe Synthetic Biology Market Value (US$ Bn) Forecast, by Environment, 2020 to 2035
Table 25: Asia Pacific Synthetic Biology Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2035
Table 26: Asia Pacific Synthetic Biology Market Value (US$ Bn) Forecast, by Tools, 2020 to 2035
Table 27: Asia Pacific Synthetic Biology Market Value (US$ Bn) Forecast, by Technology, 2020 to 2035
Table 28: Asia Pacific Synthetic Biology Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
Table 29: Asia Pacific Synthetic Biology Market Value (US$ Bn) Forecast, by End-user, 2020 to 2035
Table 30: Asia Pacific Synthetic Biology Market Value (US$ Bn) Forecast, by Healthcare, 2020 to 2035
Table 31: Asia Pacific Synthetic Biology Market Value (US$ Bn) Forecast, by Industry, 2020 to 2035
Table 32: Asia Pacific Synthetic Biology Market Value (US$ Bn) Forecast, by Environment, 2020 to 2035
Table 33: Latin America Synthetic Biology Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2035
Table 34: Latin America Synthetic Biology Market Value (US$ Bn) Forecast, by Tools, 2020 to 2035
Table 35: Latin America Synthetic Biology Market Value (US$ Bn) Forecast, by Technology, 2020 to 2035
Table 36: Latin America Synthetic Biology Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
Table 37: Latin America Synthetic Biology Market Value (US$ Bn) Forecast, by End-user, 2020 to 2035
Table 38: Latin America Synthetic Biology Market Value (US$ Bn) Forecast, by Healthcare, 2020 to 2035
Table 39: Latin America Synthetic Biology Market Value (US$ Bn) Forecast, by Industry, 2020 to 2035
Table 40: Latin America Synthetic Biology Market Value (US$ Bn) Forecast, by Environment, 2020 to 2035
Table 41: Middle East & Africa Synthetic Biology Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2035
Table 42: Middle East and Africa Synthetic Biology Market Value (US$ Bn) Forecast, by Tools, 2020 to 2035
Table 43: Middle East and Africa Synthetic Biology Market Value (US$ Bn) Forecast, by Technology, 2020 to 2035
Table 44: Middle East and Africa Synthetic Biology Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
Table 45: Middle East and Africa Synthetic Biology Market Value (US$ Bn) Forecast, by End-user, 2020 to 2035
Table 46: Middle East and Africa Synthetic Biology Market Value (US$ Bn) Forecast, by Healthcare, 2020 to 2035
Table 47: Middle East and Africa Synthetic Biology Market Value (US$ Bn) Forecast, by Industry, 2020 to 2035
Table 48: Middle East and Africa Synthetic Biology Market Value (US$ Bn) Forecast, by Environment, 2020 to 2035
List of Figures
Figure 01: Global Synthetic Biology Market Value Share Analysis, by Tools, 2024 and 2035
Figure 02: Global Synthetic Biology Market Attractiveness Analysis, by Tools, 2025 to 2035
Figure 03: Global Synthetic Biology Market Revenue (US$ Mn), by Oligonucleotides & Synthetic DNA, 2020 to 2035
Figure 04: Global Synthetic Biology Market Revenue (US$ Mn), by Enzymes, 2020 to 2035
Figure 05: Global Synthetic Biology Market Revenue (US$ Mn), by Cloning Technology Kits, 2020 to 2035
Figure 06: Global Synthetic Biology Market Revenue (US$ Mn), by Synthetic Cells, 2020 to 2035
Figure 07: Global Synthetic Biology Market Revenue (US$ Mn), by Chassis Organisms, 2020 to 2035
Figure 08: Global Synthetic Biology Market Revenue (US$ Mn), by Others, 2020 to 2035
Figure 09: Global Synthetic Biology Market Value Share Analysis, by Technology, 2024 and 2035
Figure 10: Global Synthetic Biology Market Attractiveness Analysis, by Technology, 2025 to 2035
Figure 11: Global Synthetic Biology Market Revenue (US$ Mn), by Gene Synthesis, 2020 to 2035
Figure 12: Global Synthetic Biology Market Revenue (US$ Mn), by Genome Engineering, 2020 to 2035
Figure 13: Global Synthetic Biology Market Revenue (US$ Mn), by Sequencing, 2020 to 2035
Figure 14: Global Synthetic Biology Market Revenue (US$ Mn), by Bioinformatics, 2020 to 2035
Figure 15: Global Synthetic Biology Market Revenue (US$ Mn), by Cloning, 2020 to 2035
Figure 16: Global Synthetic Biology Market Revenue (US$ Mn), by Site-Directed Mutagenesis, 2020 to 2035
Figure 17: Global Synthetic Biology Market Revenue (US$ Mn), by Others, 2020 to 2035
Figure 18: Global Synthetic Biology Market Value Share Analysis, by Application, 2024 and 2035
Figure 19: Global Synthetic Biology Market Attractiveness Analysis, by Application, 2025 to 2035
Figure 20: Global Synthetic Biology Market Revenue (US$ Mn), by Biosensors, 2020 to 2035
Figure 21: Global Synthetic Biology Market Revenue (US$ Mn), by Biological Computers, 2020 to 2035
Figure 22: Global Synthetic Biology Market Revenue (US$ Mn), by Cell Transformation, 2020 to 2035
Figure 23: Global Synthetic Biology Market Revenue (US$ Mn), by Proteins Designing, 2020 to 2035
Figure 24: Global Synthetic Biology Market Revenue (US$ Mn), by Others, 2020 to 2035
Figure 25: Global Synthetic Biology Market Value Share Analysis, by End-user, 2024 and 2035
Figure 26: Global Synthetic Biology Market Attractiveness Analysis, by End-user, 2025 to 2035
Figure 27: Global Synthetic Biology Market Revenue (US$ Mn), by Healthcare, 2020 to 2035
Figure 28: Global Synthetic Biology Market Revenue (US$ Mn), by Industry, 2020 to 2035
Figure 29: Global Synthetic Biology Market Revenue (US$ Mn), by Environment, 2020 to 2035
Figure 30: Global Synthetic Biology Market Revenue (US$ Mn), by Others, 2020 to 2035
Figure 31: Global Synthetic Biology Market Value Share Analysis, By Region, 2024 and 2035
Figure 32: Global Synthetic Biology Market Attractiveness Analysis, By Region, 2025 to 2035
Figure 33: North America Synthetic Biology Market Value (US$ Mn) Forecast, 2020 to 2035
Figure 34: North America Synthetic Biology Market Value Share Analysis, by Country, 2024 and 2035
Figure 35: North America Synthetic Biology Market Attractiveness Analysis, by Country, 2025 to 2035
Figure 36: North America Synthetic Biology Market Value Share Analysis, by Tools, 2024 and 2035
Figure 37: North America Synthetic Biology Market Attractiveness Analysis, by Tools, 2025 to 2035
Figure 38: North America Synthetic Biology Market Value Share Analysis, by Technology, 2025 to 2035
Figure 39: North America Synthetic Biology Market Attractiveness Analysis, by Technology, 2025 to 2035
Figure 40: North America Synthetic Biology Market Value Share Analysis, by Application, 2024 and 2035
Figure 41: North America Synthetic Biology Market Attractiveness Analysis, by Application, 2025 to 2035
Figure 42: North America Synthetic Biology Market Value Share Analysis, by End-user, 2024 and 2035
Figure 43: North America Synthetic Biology Market Attractiveness Analysis, by End-user, 2025 to 2035
Figure 44: Europe Synthetic Biology Market Value (US$ Mn) Forecast, 2020 to 2035
Figure 45: Europe Synthetic Biology Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 46: Europe Synthetic Biology Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
Figure 47: Europe Synthetic Biology Market Value Share Analysis, by Tools, 2024 and 2035
Figure 48: Europe Synthetic Biology Market Attractiveness Analysis, by Tools, 2025 to 2035
Figure 49: Europe Synthetic Biology Market Value Share Analysis, by Technology, 2024 and 2035
Figure 50: Europe Synthetic Biology Market Attractiveness Analysis, by Technology, 2025 to 2035
Figure 51: Europe Synthetic Biology Market Value Share Analysis, By Application, 2024 and 2035
Figure 52: Europe Synthetic Biology Market Attractiveness Analysis, By Application, 2025 to 2035
Figure 53: Europe Synthetic Biology Market Value Share Analysis, by End-user, 2024 and 2035
Figure 54: Europe Synthetic Biology Market Attractiveness Analysis, by End-user, 2025 to 2035
Figure 55: Asia Pacific Synthetic Biology Market Value (US$ Mn) Forecast, 2020 to 2035
Figure 56: Asia Pacific Synthetic Biology Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 57: Asia Pacific Synthetic Biology Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
Figure 58: Asia Pacific Synthetic Biology Market Value Share Analysis, by Tools, 2024 and 2035
Figure 59: Asia Pacific Synthetic Biology Market Attractiveness Analysis, by Tools, 2025 to 2035
Figure 60: Asia Pacific Synthetic Biology Market Value Share Analysis, by Technology, 2024 and 2035
Figure 61: Asia Pacific Synthetic Biology Market Attractiveness Analysis, by Technology, 2025 to 2035
Figure 62: Asia Pacific Synthetic Biology Market Value Share Analysis, By Application, 2024 and 2035
Figure 63: Asia Pacific Synthetic Biology Market Attractiveness Analysis, By Application, 2025 to 2035
Figure 64: Asia Pacific Synthetic Biology Market Value Share Analysis, by End-user, 2024 and 2035
Figure 65: Asia Pacific Synthetic Biology Market Attractiveness Analysis, by End-user, 2025 to 2035
Figure 66: Latin America Synthetic Biology Market Value (US$ Mn) Forecast, 2020 to 2035
Figure 67: Latin America Synthetic Biology Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 68: Latin America Synthetic Biology Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
Figure 69: Latin America Synthetic Biology Market Value Share Analysis, by Tools, 2024 and 2035
Figure 70: Latin America Synthetic Biology Market Attractiveness Analysis, by Tools, 2025 to 2035
Figure 71: Latin America Synthetic Biology Market Value Share Analysis, by Technology, 2024 and 2035
Figure 72: Latin America Synthetic Biology Market Attractiveness Analysis, by Technology, 2025 to 2035
Figure 73: Latin America Synthetic Biology Market Value Share Analysis, By Application, 2024 and 2035
Figure 74: Latin America Synthetic Biology Market Attractiveness Analysis, By Application, 2025 to 2035
Figure 75: Latin America Synthetic Biology Market Value Share Analysis, by End-user, 2024 and 2035
Figure 76: Latin America Synthetic Biology Market Attractiveness Analysis, by End-user, 2025 to 2035
Figure 77: Middle East & Africa Synthetic Biology Market Value (US$ Mn) Forecast, 2020 to 2035
Figure 78: Middle East & Africa Synthetic Biology Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 79: Middle East & Africa Synthetic Biology Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
Figure 80: Middle East and Africa Synthetic Biology Market Value Share Analysis, by Tools, 2024 and 2035
Figure 81: Middle East and Africa Synthetic Biology Market Attractiveness Analysis, by Tools, 2025 to 2035
Figure 82: Middle East and Africa Synthetic Biology Market Value Share Analysis, by Technology, 2024 and 2035
Figure 83: Middle East and Africa Synthetic Biology Market Attractiveness Analysis, by Technology, 2025 to 2035
Figure 84: Middle East and Africa Synthetic Biology Market Value Share Analysis, by Application, 2024 and 2035
Figure 85: Middle East and Africa Synthetic Biology Market Attractiveness Analysis, By Application, 2025 to 2035
Figure 86: Middle East and Africa Synthetic Biology Market Value Share Analysis, by End-user, 2024 and 2035
Figure 87: Middle East and Africa Synthetic Biology Market Attractiveness Analysis, by End-user, 2025 to 2035
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Synthetic Biology Market